Our model using BMI, renal function, triglyceride-glucose index, serum alanine aminotransferase, and hemoglobin accurately predicted the presence of NAFLD in CKD patients. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.